PLoS ONE (Jan 2021)

Characterization of a L136P mutation in Formin-like 2 (FMNL2) from a patient with chronic inflammatory bowel disease.

  • Raphael Trefzer,
  • Orly Elpeleg,
  • Tatyana Gabrusskaya,
  • Polina Stepensky,
  • Hagar Mor-Shaked,
  • Robert Grosse,
  • Dominique T Brandt

DOI
https://doi.org/10.1371/journal.pone.0252428
Journal volume & issue
Vol. 16, no. 5
p. e0252428

Abstract

Read online

Diaphanous related formins are highly conserved proteins regulated by Rho-GTPases that act as actin nucleation and assembly factors. Here we report the functional characterization of a non-inherited heterozygous FMNL2 p.L136P mutation carried by a patient who presented with severe very early onset inflammatory bowel disease (IBD). We found that the FMNL2 L136P protein displayed subcellular mislocalization and deregulated protein autoinhibition indicating gain-of-function mechanism. Expression of FMNL2 L136P impaired cell spreading as well as filopodia formation. THP-1 macrophages expressing FMNL2 L136P revealed dysregulated podosome formation and a defect in matrix degradation. Our data indicate that the L136P mutation affects cellular actin dynamics in fibroblasts and immune cells such as macrophages.